@article{Reyes_L-2022_219974,
title = {Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study},
author = {Reyes, L. and Murthy, S. and Garcia-Gallo, E. and Merson, L. and Ibáñez-Prada, E. and Rello, J. and Fuentes, Y. and Martin-Loeches, I. and Bozza, F. and Duque, S. and Taccone, F. and Fowler, R. and Kartsonaki, C. and Gonçalves, B. and Wanjiru Citarella, B. and Aryal, D. and Burhan, E. and Cummings, M. and Delmas, C. and Diaz, R. and Figueiredo-Mello, C. and Hashmi, M. and Panda, P. and Pedrera Jiménez, M. and ISARIC Clinical Characterization Group},
month = {sep},
year = {2022},
abstract = {Background Up to 30% of hospitalised patients with COVID-19 require advanced respiratory support, including high-flow nasal cannulas (HFNC), non-invasive mechanical ventilation (NIV), or invasive mechanical ventilation (IMV). We aimed to describe the clinical characteristics, outcomes and risk factors for failing non-invasive respiratory support in patients treated with severe COVID-19 during the first two years of the pandemic in high-income countries (HICs) and low middle-income countries (LMICs).},
volume = {26},
journal = {Critical Care},
publisher = {Springer Nature},
url = {https://doi.org/10.1186/s13054-022-04155-1},
}
